康艾注射液联合化疗治疗晚期肺癌的临床观察  

Clinical Study of Kangai Injection Combined with Chemotherapy in the Treatment of Advanced Lung Cancer

作　　者：王大鹏[1] 徐忠玲[1] 张伟[1] 刘晶[1] 张程[1] 

机构地区：[1]齐齐哈尔医学院附属肿瘤医院化疗科,黑龙江齐齐哈尔161002

出　　处：《中国现代医生》2009年第26期54-55,共2页China Modern Doctor

摘　　要：目的提高晚期肺癌患者的生活质量,减轻化疗引起的毒副作用,从而提高机体免疫功能。方法治疗组采用康艾注射液60ml加入5%葡萄糖或0.9%生理盐水250～500ml稀释后静脉点滴,1次/d,30d为1个疗程,同时合并全身化疗,对照组单用化疗。结果治疗组有效率47.5%,对照组有效率37.5%。结论康艾注射液联合化疗可提高患者的生活质量、减轻毒副反应,且可提高患者免疫功能。Objective To improve the patients with advanced lung cancer quality of life,reduce the chemotherapy-induced side effects, thereby enhancing immune function. Methods The treatment group Kangai injection 60 ml in 5% glucose or 0.9% NS 250-500 ml diluted intravenous drip,once/d, 30 d for a course of treatment, combined with chemotherapy. The control group alone with chemotherapy. Results 47.5% effective in the treatment group, 37.5% effective in the control group. Conclusion Kangai injection combined with chemotherapy can improve the quality of life of patients and reduce the toxicity, and enhance immune function in patients.

关 键 词：康艾注射液 晚期肺癌 化学治疗 

分 类 号：R563.9[医药卫生—呼吸系统]